PR Newswire Clinical TrialsOriginal article
Imbed Biosciences' DualGuard™ Silver-Gallium Matrix Safety Study Now Registered on ClinicalTrials.gov
Trial StartDualGuard™ Silver-Gallium MatrixPositive
AI Analysis
Summary
Imbed Biosciences registered a safety study for DualGuard™ Silver-Gallium Matrix on ClinicalTrials.gov (NCT07695688) to address biofilm challenges in wound care. The study represents the company's ongoing development of its SAMatrix technology platform.
Clinical Trial Data
NCT ID
Importance:3/10
Sentiment:
0.30
clinical trial registrationwound carebiofilmantimicrobial matrix
Read the original article
Published by PR Newswire Clinical Trials on October 1, 2026 1:54 PM